The ADENOMA Study. Accuracy of Detection using Endocuff Vision™ Optimization of Mucosal Abnormalities: study protocol for randomized controlled trial

Background: Colonoscopy is the gold standard investigation for the diagnosis of bowel pathology and colorectal cancer screening. Adenoma detection rate is a marker of high quality colonoscopy and a high adenoma detection rate is associated with a lower incidence of interval cancers. Several technological advancements have been explored to improve adenoma detection rate. A new device called Endocuff Vision™ has been shown to improve adenoma detection rate in pilot studies.

Methods/Design: This is a prospective, multicenter, randomized controlled trial comparing the adenoma detection rate in patients undergoing Endocuff Vision™-assisted colonoscopy with standard colonoscopy. All patients above 18 years of age referred for screening, surveillance, or diagnostic colonoscopy who are able to consent are invited to the study. Patients with absolute contraindications to colonoscopy, large bowel obstruction or pseudo-obstruction, colon cancer or polyposis syndromes, colonic strictures, severe diverticular segments, active colitis, anticoagulant therapy, or pregnancy are excluded. Patients are randomized according to site, age, sex, and bowel cancer screening status to receive Endocuff Vision™-assisted colonoscopy or standard colonoscopy on the day of procedure. Baseline data, colonoscopy, and polyp data including histology are collected. Nurse assessment of patient comfort and patient comfort questionnaires are completed post procedure. Patients are followed up at 21 days and complete a patient experience questionnaire. This study will take place across seven NHS Hospital Trusts: one in London and six within the Northern Region Endoscopy Group. A maximum of 10 colonoscopists per site will recruit a total of 1772 patients, with a maximum of four bowel screening colonoscopists permitted per site.

Discussion: This is the first trial to evaluate the adenoma detection rate of Endocuff Vision™ in all screening, surveillance, and diagnostic patient groups. This timely study will guide clinicians as to the role of Endocuff Vision™ in routine colonoscopy.

Study registration: ISRCTN11821044.

• References

• 1 Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. NEJM 2010; 362: 1795-1803
• 2 Corley DA, Jensen CD, Marks AR et al. Adenoma detection rate and risk of colorectal cancer and death. NEJM 2014; 370: 1298-1306
• 3 Lee TJ, Rutter MD, Blanks RG et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 2012; 61: 1050-1057
• 4 Rajasekhar PT, Lee TJ, Rutter MD et al. Using a ‘conversion factor’ to estimate adenoma detection rate. Endoscopy 2012; 61: A371
• 5 Bowles CJ, Leicester R, Romaya C et al. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow?. Gut 2004; 53: 277-283
• 6 Gavin DR, Valori RM, Anderson JT et al. The national colonoscopy audit: a nationwide assessment of the quality and safety of colonoscopy in the UK. Gut 2013; 62: 242-249
• 7 Faiss S. The missed colorectal cancer problem. Dig Dis 2011; 29: 60-63
• 8 Rees CJ, Rajasekhar PT, Rutter MD et al. Quality in colonoscopy: European perspectives and practice. Expert Rev Gastroenterol Hepatol 2014; 8: 29-47
• 9 Siersema PD, Rastogi A, Leufkens AM et al. Retrograde-viewing device improves adenoma detection rate in colonoscopies for surveillance and diagnostic workup. World J Gastroenterol 2012; 18: 3400-3408
• 10 Kaltenbach T, Friedland S, Soetikno R. A randomised tandem colonoscopy trial of narrow band imaging versus white light examination to compare neoplasia miss rates. Gut 2008; 57: 1406-1412
• 11 Fenlon HM, Nunes DP, Clarke PD et al. Colorectal neoplasm detection using virtual colonoscopy: a feasibility study. Gut 1998; 43: 806-811
• 12 East JE, Bassett P, Arebi N et al. Dynamic patient position changes during colonoscope withdrawal increase adenoma detection: a randomized, crossover trial. Gastrointest Endosc 2011; 73: 456-463
• 13 Saifuddin T, Trivedi M, King PD et al. Usefulness of a pediatric colonoscope for colonoscopy in adults. Gastrointest Endosc 2000; 51: 314-317
• 14 Harada Y, Hirasawa D, Fujita N et al. Impact of a transparent hood on the performance of total colonoscopy: a randomized controlled trial. Gastrointest Endosc 2009; 69: 637-644
• 15 Rastogi A, Bansal A, Rao DS et al. Higher adenoma detection rates with cap-assisted colonoscopy: a randomised controlled trial. Gut 2012; 61: 402-408
• 16 Tsiamoulos ZP, Kinesh PP, Elliott TR et al. Does Endocuff-Vision improve adenoma detection rate at screening colonoscopy?. Gastrointest Endosc 2014; 79: AB233-AB234
• 17 Tsiamoulos ZP, Saunders BP. A new accessory, endoscopic cuff, improves colonoscopic access for complex polyp resection and scar assessment in the sigmoid colon (with video). Gastrointest Endosc 2012; 76: 1242-1245
• 18 Russell D, Hoare ZS, Whitaker R et al. Generalized method for adaptive randomization in clinical trials. Stat Med 2011; 30: 922-934
• 19 Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002; 51 (Suppl. 05) 6-9
• 20 NHS Cancer Screening Programmes. Adenoma Surveillance: BSCP Guidance. 2009 http://www.cancerscreening.nhs.uk/bowel/publications/nhsbcsp-guidance-note-1.pdf Accessed 25 February 2014
• 21 Leslie A, Carey FA, Pratt NR et al. The colorectal adenoma-carcinoma sequence. Br J Surg 2002; 89: 845-860
• 22 Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-2270
• 23 Rajasekhar PT, Rutter MD, Bramble MG et al. Achieving high quality colonoscopy: using graphical representation to measure performance and reset standards. Colorectal Dis 2012; 14: 1538-1545
• 24 NHS Bowel Cancer Screening Programme. Accreditation of screening colonoscopists. 2006: 1-43 Available from: http://www.saas.nhs.uk/Downloads.aspx